Ads by Google
The most effective way to fight breast cancer is to detect it early and a proper breast self-examination can help, although the most effective tools to detect breast cancer are mammography and clinical breast exam by your doctor. Women who perform regular breast self-exams find 90% of all breast masses. This video shows you how to perform a self-exam.
Study reveals in detail how breast cells produce new cells that are predisposed to become cancerous, unless they receive the protective action of the CHFR gene.
Bionovo announced results on the role of estrogen regulatory elements important in developing drugs for breast cancer and osteoporosis. The data, which were presented at the Endocrine Society's 90th Annual Meeting, showed that the new regulatory elements are essential for the differentiation of the estrogenic pharmacological activity exerted by different compounds.
Researchers have shown in a new study that low melatonin levels are associated with an increased risk of breast cancer in postmenopausal women.
Tanespimycin demonstrated a high level of antitumor activity in a Phase 2 trial when administered in combination with trastuzumab to patients with HER2-positive metastatic breast cancer.
Pre-menopausal breast cancer survivors who were treated with chemotherapy following surgery were more likely to have diminished ovarian reserve compared to women who have never had breast cancer.
Black and Hispanic women are less likely than white women to receive the radiation therapy routinely prescribed following surgery for early breast cancer.
Women, who took Zoledronic acid (a bisphosphonate) in a recent trial, were found to have a 36 percent reduction of breast cancer recurrence when compared to a group who did not take the drug.
Pre-menopausal breast cancer survivors who were treated with chemotherapy following surgery were more likely to have diminished ovarian reserve - the capacity of the ovaries to provide eggs capable of being fertilized - compared to women who have never had breast cancer.
Genomic Health's study confirms RT-PCR by Oncotype DX can deliver quantitative gene expression levels for assessing estrogen receptor and progesterone receptor status, which are critical factors in determining the use and benefit of hormonal therapy for the treatment of breast cancer.
Ipsogen SA is entering the breast cancer diagnostic market with the European launch of MapQuant Dx Genomic Grade. MapQuant Dx Genomic Grade is the very first molecular diagnostic test to accurately measure tumor grade, a consensus indicator of tumor proliferation, risk of metastasis and response to chemotherapy.
Cancer treatment drug Avastin significantly helps Metastatic Breast Cancer patients by increasing the chance of living without breast cancer progression, shows the phase III AVADO study presented at ASCO.
Young women who have been diagnosed with breast cancer have gathered to share their experiences at a two-day conference in Swansea.
Continuing Herceptin treatment prevents disease progression in women with aggressive metastatic breast cancer. Women with HER2-positive breast cancer benefit from nearly three extra months of life without progression.
Women with high-risk node-negative early stage breast cancer adjuvant treatment with Taxotere Injection Concentrate was associated with a significant improvement in DFS compared to a standard FAC regimen in the GEICAM 9805/Target-0 study.